Article
LIN28B promotes the development of neuroendocrine prostate cancer
7 Jul 2020
Abstract excerpt
Therapy-induced neuroendocrine prostate cancer (t-NEPC) is a highly aggressive subtype of prostate cancer with poor patient survival. Emerging evidence indicates that t-NEPC can develop when prostate adenocarcinoma cells acquire cancer stem-like cell signaling in the presence of androgen receptor inhibition, followed by redifferentiation toward neuroendocrine lineage and subsequent t-NEPC progression. Whether the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
